Investigational 2022
Top Research Directions
The 1 research directions with Investigational 2022 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.
| # | Direction | Papers | Share |
|---|---|---|---|
| 1 | Overcoming Systemic Toxicity in Cancer Immunotherapy | 1 | 50.0% |
Download all directions as CSV
Institutions
Institutions credited by Investigational 2022 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.
| # | Institution | Papers | Share |
|---|---|---|---|
| 1 | Sichuan University | 1 | 100.0% |
Download all institutions as CSV
About this data
Papers. Investigational 2022 lists 2 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.
Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.
Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 2 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.
Data. Counts come from Lacuna’s data build of 2026-11-18 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Investigational 2022”, https://lacuna.tiptreesystems.com/venue/investigational/2022.
Papers
| Title |
|---|
| A small molecule inhibitor of VSIG-8 prevents its binding to VISTA |
| Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma |